These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31064778)

  • 21. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype.
    Yeh N; Glosson NL; Wang N; Guindon L; McKinley C; Hamada H; Li Q; Dutton RW; Shrikant P; Zhou B; Brutkiewicz RR; Blum JS; Kaplan MH
    J Immunol; 2010 Aug; 185(4):2089-98. PubMed ID: 20624947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice.
    Minev BR; McFarland BJ; Spiess PJ; Rosenberg SA; Restifo NP
    Cancer Res; 1994 Aug; 54(15):4155-61. PubMed ID: 7518351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.
    Bowers JS; Nelson MH; Kundimi S; Bailey SR; Huff LW; Schwartz KM; Cole DJ; Rubinstein MP; Paulos CM
    Clin Cancer Res; 2015 Jun; 21(11):2546-57. PubMed ID: 25904754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
    Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
    Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CTLA-4 (CD152) enhances the Tc17 differentiation program.
    Pick J; Arra A; Lingel H; Hegel JK; Huber M; Nishanth G; Jorch G; Fischer KD; Schlüter D; Tedford K; Brunner-Weinzierl MC
    Eur J Immunol; 2014 Jul; 44(7):2139-52. PubMed ID: 24723371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation.
    Zhang R; Fang H; Chen R; Ochando JC; Ding Y; Xu J
    Transplantation; 2018 Dec; 102(12):e483-e493. PubMed ID: 30211827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.
    Flores-Santibáñez F; Fernández D; Meza D; Tejón G; Vargas L; Varela-Nallar L; Arredondo S; Guixé V; Rosemblatt M; Bono MR; Sauma D
    Immunology; 2015 Dec; 146(4):582-94. PubMed ID: 26331349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women.
    d'Ettorre G; Borrazzo C; Pinacchio C; Santinelli L; Cavallari EN; Statzu M; Fanello G; Ceccarelli G; Antonelli G; Vullo V; Mastroianni CM; Scagnolari C
    AIDS; 2019 Mar; 33(4):627-636. PubMed ID: 30608274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-γ- and IL-17-producing CD8
    Ohkuri T; Kosaka A; Ikeura M; Salazar AM; Okada H
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34193567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.
    Pegram HJ; Lee JC; Hayman EG; Imperato GH; Tedder TF; Sadelain M; Brentjens RJ
    Blood; 2012 May; 119(18):4133-41. PubMed ID: 22354001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-23 drives pathogenic IL-17-producing CD8+ T cells.
    Ciric B; El-behi M; Cabrera R; Zhang GX; Rostami A
    J Immunol; 2009 May; 182(9):5296-305. PubMed ID: 19380776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses.
    McCabe BJ; Irvine KR; Nishimura MI; Yang JC; Spiess PJ; Shulman EP; Rosenberg SA; Restifo NP
    Cancer Res; 1995 Apr; 55(8):1741-7. PubMed ID: 7536130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinforce the antitumor activity of CD8
    Nabe S; Yamada T; Suzuki J; Toriyama K; Yasuoka T; Kuwahara M; Shiraishi A; Takenaka K; Yasukawa M; Yamashita M
    Cancer Sci; 2018 Dec; 109(12):3737-3750. PubMed ID: 30302856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Committed Tc17 cells are phenotypically and functionally resistant to the effects of IL-27.
    El-Behi M; Dai H; Magalhaes JG; Hwang D; Zhang GX; Rostami A; Ciric B
    Eur J Immunol; 2014 Oct; 44(10):3003-14. PubMed ID: 25070084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-β and IL-21 cooperatively stimulate activated CD8(+) T cells to differentiate into Tc17 cells.
    Chen HW; Tsai JP; Yao TY; Hsieh CL; Chen IH; Liu SJ
    Immunol Lett; 2016 Jun; 174():23-7. PubMed ID: 27085379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H; Li F; Gordon JR; Xiang J
    Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
    Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
    Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
    Winter H; Hu HM; McClain K; Urba WJ; Fox BA
    J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
    Lancki DW; Hsieh CS; Fitch FW
    J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.